Epigenetics Market : Moving Towards Brighter Future

1. Opportunity Analysis and Industry Forecast, 2016-2023 Epigenetics Market : Moving Towards Brighter Future Global Opportunity Analysis and Industry Forecast, 2017-2023

2. Epigenetics Market “Epigenetics has provided hope for advanced cancer treatment, and is expected to be the one of the most effective treatment options for diseases in future, especially cancer. The rise in awareness about epigenetic factors and their role in developmental & disease biology are anticipated to create lucrative opportunities in the forecast period.”

3. Epigenetics Market Overview According to a new report published by Allied Market Research, titled, "Epigenetics Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global epigenetics market was valued at $555 million in 2016, and is projected to reach $1,321 million by 2023, growing at a CAGR of 13.1% from 2017 to 2023. The DNA-modifying enzymes segment witnessed the highest rate, generating maximum revenue in the market in 2016. Access Full Summary at: https://www.alliedmarketresearch.com/epigenetics-market Epigenetics is an area of developmental biology that involves the study of cellular and physiological trait variations initiated by external or ecological aspects. This external stimulus swipe genes on and off and affect the ability of cells to read genes. Epigenetics changes the organisms phenotype rather than the genotype, wherein the underlying DNA or RNA sequence remains unchanged. For instance, DNA methylation and histone modification are epigenetic processes wherein the alteration in gene expression is observed without the change in the DNA sequence.

4. Epigenetics Market The epigenetics market is segmented based on product, application, end user, and geography. Based on product, it is divided into enzymes, kits & assays, instruments, and, reagents. Enzymes are further classified into DNA ligases, DNA polymerases, other DNA-modifying enzymes, acetylases, methyltransferases, other protein-modifying enzymes, reverse transcriptase, RNA ligases, and other RNA-modifying enzymes. Kits & assays are further subdivided into bisulfite conversion kits, chip-seq kits, deep sequencing kits, methyltransferase assays, histone assays, immunoprecipitation kits, and other epigenetic kits. Based on instruments, the market is further sub segmented into mass spectrometers, next-generation sequencers, qPCRs, and sonicators & other instruments.   On the basis of application, the market is bifurcated into oncology and non-oncology. Oncology is further sub-segmented into solid tumors & liquid tumors and non-oncology is further categorized into inflammatory diseases, metabolic diseases, infectious diseases, cardiovascular diseases, developmental biology, drug discovery, and other applications.

5. Epigenetics Market Snapshot The market is expected to witness a moderate growth during the forecast period, owing to the rise in epigenetic drug discovery. Furthermore, surge in prevalence of cancer and technological advancements in epigenetics research are anticipated to augment the market growth. The untapped potential of emerging markets, such as China and India, is expected to present various opportunities for market expansion. However, high costs of instruments and dearth of skilled personnel are expected to hamper the market growth. The report provides extensive competitive analysis and profiles of key market players, such as Abcam Plc., Illumina, QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Epizyme Inc., Thermo Fisher Scientific, Inc., Active Motif. Diagenode, Inc., and Zymo Research Corporation. The other players in the value chain include Domainex, CellCentric Ltd., Chroma Therapeutics Ltd., Eisai Co. Ltd., Novartis International AG, Oncolys Biopharma Inc., Syndax Pharmaceuticals, Inc., and Valirx plc.

6. This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities. • Market estimations are based on comprehensive analysis of the key developments in the industry. • In-depth analysis based on geography assists to understand the regional market and the strategic business planning. • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market. Key Benefits of Epigenetics Market

7. Epigenetics Market North America Europe Asia-Pacific LAMEA

8. Epigenetics Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/846 Follow Us On